Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study

NCT06575127 is registered in ClinicalTrials.gov with Al-Azhar University as lead sponsor.

NCT NCT06575127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06575127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study
Lead sponsor
Al-Azhar University
Phase
Phase 2
Overall status
Recruiting
Start date
August 17, 2024
Completion date
September 1, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer stage 4, neoplasm malignant